
Sign up to save your podcasts
Or


Vectus Biosystems: Could this drug eventually prevent thousands of deaths?
Listen to ASX-listed Vectus Biosystems CEO Karen Duggan talk to Matt Birney on the Bulls N’ Bears Report about Vectus’ rapidly developing treatment for a condition that is a factor in up to 40 per cent of all deaths.
See omnystudio.com/listener for privacy information.
By Bulls N' Bears on 6PR RadioVectus Biosystems: Could this drug eventually prevent thousands of deaths?
Listen to ASX-listed Vectus Biosystems CEO Karen Duggan talk to Matt Birney on the Bulls N’ Bears Report about Vectus’ rapidly developing treatment for a condition that is a factor in up to 40 per cent of all deaths.
See omnystudio.com/listener for privacy information.

55 Listeners

22 Listeners

63 Listeners

29 Listeners

22 Listeners

2 Listeners

4 Listeners

5 Listeners

2 Listeners

9 Listeners